Immune Health

News Watch

Research & Practice

[This article is an outside contribution by Dr Patricia Lepage (INRA), co-author of the paper. For further references about the author, see the short bio hereunder]   Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and INRA (National Agronomic Research Institute) in France has led to a rather surprising discovery on the manner in which cancer…

GMFH Editing Team
GMFH Editing Team

[This article is an outside contribution by Dr Patricia Lepage (INRA), co-author of the paper. For further references about the author, see the short bio hereunder]   Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and INRA (National Agronomic Research Institute) in France has led to a rather surprising discovery on the manner in which cancer…

GMFH Editing Team
GMFH Editing Team

Humans are not (and have never been) alone. From the moment we are born, millions of micro-organisms populate our bodies and coexist with us rather peacefully for the rest of our lives. This microbiome represents the totality of micro-organisms (and their genomes) that we necessarily acquire from the environment. Micro-organisms living in or on us have evolved to extract the…

GMFH Editing Team
GMFH Editing Team

Humans are not (and have never been) alone. From the moment we are born, millions of micro-organisms populate our bodies and coexist with us rather peacefully for the rest of our lives. This microbiome represents the totality of micro-organisms (and their genomes) that we necessarily acquire from the environment. Micro-organisms living in or on us have evolved to extract the…

GMFH Editing Team
GMFH Editing Team

Speakers: Anne Vrieze (Netherlands), Lawrence Brandt (USA)   Dr Vrieze’s talk focused on faecal microbiota transplantation (FMT) as a therapy for metabolic syndrome and C. difficile inflammation (CDI), under the guiding question whether the lacking diversity of the gut microbiota, which is assumed to play a major role in the disease onset, can be restored by the infusion of donor…

GMFH Editing Team
GMFH Editing Team

Speakers: Anne Vrieze (Netherlands), Lawrence Brandt (USA)   Dr Vrieze’s talk focused on faecal microbiota transplantation (FMT) as a therapy for metabolic syndrome and C. difficile inflammation (CDI), under the guiding question whether the lacking diversity of the gut microbiota, which is assumed to play a major role in the disease onset, can be restored by the infusion of donor…

GMFH Editing Team
GMFH Editing Team

Knowing how microbiota is established in the gut is a very important topic regarding epithelium maturation and immune system developpement. The early studies focused on the dynamic of the microbiota in infant aiming to understand homeostasy mecanisms. The early life microbiota show a low diversity but an high variation in term of species abundance between infants. One of the basic…

GMFH Editing Team
GMFH Editing Team

Knowing how microbiota is established in the gut is a very important topic regarding epithelium maturation and immune system developpement. The early studies focused on the dynamic of the microbiota in infant aiming to understand homeostasy mecanisms. The early life microbiota show a low diversity but an high variation in term of species abundance between infants. One of the basic…

GMFH Editing Team
GMFH Editing Team

Stool transplants highly efficient for Clostridium difficile infections and other gastrointestinal conditions — online press conference at 2nd World Summit “Gut Microbiota For Health” held today (26 February 2013) Clostridium difficile infections have developed into a virtual pandemic over the past two decades. The outcome of standard antibiotic treatment is unsatisfactory: the recurrence rates are high with every relapse increasing…

GMFH Editing Team
GMFH Editing Team

Stool transplants highly efficient for Clostridium difficile infections and other gastrointestinal conditions — online press conference at 2nd World Summit “Gut Microbiota For Health” held today (26 February 2013) Clostridium difficile infections have developed into a virtual pandemic over the past two decades. The outcome of standard antibiotic treatment is unsatisfactory: the recurrence rates are high with every relapse increasing…

GMFH Editing Team
GMFH Editing Team